| 000 | 01881 a2200469 4500 | ||
|---|---|---|---|
| 005 | 20250518010804.0 | ||
| 264 | 0 | _c20200311 | |
| 008 | 202003s 0 0 eng d | ||
| 022 | _a1941-2703 | ||
| 024 | 7 |
_a10.1089/jamp.2018.1477 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aKerwin, Edward M | |
| 245 | 0 | 0 |
_aSatisfaction with the Use of eFlow Closed-System Nebulizer in Patients with Moderate-to-Very Severe Chronic Obstructive Pulmonary Disease: Findings from a Long-Term Safety Study. _h[electronic resource] |
| 260 |
_bJournal of aerosol medicine and pulmonary drug delivery _c02 2019 |
||
| 300 |
_a24-33 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdministration, Inhalation |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aBronchodilator Agents _xadministration & dosage |
| 650 | 0 | 4 | _aEquipment Design |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aGlycopyrrolate _xadministration & dosage |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLung _xdrug effects |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aMuscarinic Antagonists _xadministration & dosage |
| 650 | 0 | 4 | _aNebulizers and Vaporizers |
| 650 | 0 | 4 | _aPatient Satisfaction |
| 650 | 0 | 4 |
_aPulmonary Disease, Chronic Obstructive _xdiagnosis |
| 650 | 0 | 4 | _aSeverity of Illness Index |
| 650 | 0 | 4 | _aTime Factors |
| 650 | 0 | 4 |
_aTiotropium Bromide _xadministration & dosage |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aDonohue, James F | |
| 700 | 1 | _aFerguson, Gary T | |
| 700 | 1 | _aGanapathy, Vaidyanathan | |
| 700 | 1 | _aOzol-Godfrey, Ayca | |
| 700 | 1 | _aRajagopalan, Krithika | |
| 773 | 0 |
_tJournal of aerosol medicine and pulmonary drug delivery _gvol. 32 _gno. 1 _gp. 24-33 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1089/jamp.2018.1477 _zAvailable from publisher's website |
| 999 |
_c29072177 _d29072177 |
||